Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation

Annals of the New York Academy of Sciences

Volumn 965, Issue , 2002, Pages 28-46

  Onaivi, Emmanuel S ^a,b   Ali, Syed F ^c   Chirwa, Sanika S ^d   Zwiller, Jean ^e   Thiriet, Nathalie ^b   Emmanuel Akinshola, B ^f   Ishiguro, Hiroki ^b  

^a WILLIAM PATERSON UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d MEHARRY MEDICAL COLLEGE   (United States)

^e CENTRE DE NEUROCHIMIE   (France)

^f HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Addiction; Animal model; Gene chip; Haplotypes; Ibogaine; Methamphetamine; Pharmacogenomics; Pharmacotherapy: psychostimulant; Signal transduction; SNPs

Indexed keywords

AMPHETAMINE; GENE PRODUCT; IBOGAINE; METHAMPHETAMINE; PSYCHOSTIMULANT AGENT;

ALCOHOLISM; BRAIN DEPTH STIMULATION; CLINICAL TRIAL; CONFERENCE PAPER; DNA MICROARRAY; DRUG DEPENDENCE; DRUG MECHANISM; DRUG TOLERANCE; GENE EXPRESSION; GENE MAPPING; GENETIC CODE; HIPPOCAMPUS; HUMAN; IMMEDIATE EARLY GENE; LONG TERM POTENTIATION; NONHUMAN; PHARMACOGENOMICS; SIGNAL TRANSDUCTION; WITHDRAWAL REFLEX;

ANIMALIA;

EID: 0036296009     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04149.x     Document Type: Conference Paper

References (60)

1. Drugs of abuse and brain gene expression
2. Genetic and environmental influences on transitions in drug use
3. Pharmacogenomics and addiction to opiates
4. Human disease genes
5. Genetics of alcoholism and substance abuse
6. Genetic influences on smoking: Candidate genes
7. Polymorphisms in genes involved in neurotransmission in relation to smoking
8. Application of DNA microarrays to study human alcoholism
9. Chronic cocaine-mediated changes in non-human primate nucleus accumbens gene expression
10. Large-scale analysis of gene expression changes during acute and chronic exposure to D9-THC in rats
11. Learning about addiction from the genome
12. Addiction becomes a brain disease
13. Changes in gene expression and signal transduction following ibogaine treatment
14. Addiction is a brain disease, and it matters
15. Cellular responses to chronic treatment with drugs of abuse
16. Acute ibogaine injection induces expression of the immediate early genes, egr-1 and c-fos, in mouse brain
17. A cannabinoid mechanism in relapse to cocaine seeking
18. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
19. Genes and addiction
20. The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats
21. Human genetic polymorphisms
22. Polygenic inheritance and micro/minisatellites
23. A genetic association for cigarette smoking behavior
24. Evidence suggesting the role of specific genetic factors in cigarette smoking
25. ADH and ALDH polymorphisms among Alaska Natives entering treatment for alcoholism
26. Learning about addiction from the genome
27. Microarrays on the mind: Technology shows alcohol abuse changes brain's molecular programming circuitry
28. Fundamentals of DNA hybridization arrays for gene expression analysis
29. Gene expression in human alcoholism: Microarray analysis of frontal cortex
30. Alcohol's effects on gene expression
31. Chronic cocaine-mediated changes in non-human primate nucleus accumbens gene expression
32. Large-scale analysis of gene expression changes during acute and chronic exposure to D9-THC in rats
33. Transgenic mice in drug dependence research
34. In vivo ibogaine blockade and in vitro PKC action of cocaine
35. Treatment of narcolepsy with methamphetamine
36. Methamphetamine Abuse: Epidemiologic Issues and Implications
37. Methamphetamine-induced neurotoxicity: Structure activity relationships
38. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium
39. Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons
40. Cell adhesion molecules, CREB, and the formation of new synaptic connections
41. Protein F1/GAP-43 and PKC gene expression patterns in hippocampus are altered 1-2 h after LTP
42. Neurobiological actions of cocaine in the hippocampus
43. Multiple ionic conductances of the human dopamine transporter: The actions of dopamine and psychostimulants
44. Multiple human D5 dopamine receptor genes: A functional receptor
45. Expression of long-term potentiation of the striatum in methamphetamine-sensitized rats
46. Total recall - The memory of addiction
47. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons
48. Molecular cloning and expression of a D1 dopamine receptor linked to adenyl cyclase activation
49. Biochemical correlates of long-term potentiation in hippocampal synapses
50. Dopaminergic antagonists prevent long-term maintenance of posttetanic LTP in the CA1 region of rat hippocampal slices
51. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus
52. Direct evidence for biphasic cAMP responsive element-binding protein phosphorylation during long-term potentiation in the rat dentate gyrus in vivo
53. Cocaine and the AP-1 transcription factor complex
54. Drugs of abuse and immediate-early genes in the forebrain
55. ITF mapping after drugs of abuse: Pharmacological versus perceptional effect
56. Phenotype offers new perception on cocaine
57. Activation of c-fos in the brain
58. Threshold for synaptic activation of transcription factors in hippocampus: Correlation with long-term enhancement
59. Cocaine and fluoxetine induce the expression of the hVH-5 gene encoding MAP kinase phosphatase